The FDA’s Office of Prescription Drug Promotion (OPDP) announced research projects to examine whether the presence of a disclosure of four types of endorsers’ payment status influences viewers’ reactions and how proprietary names affect consumers. The agency also responded to comments on a proposed study of direct-to-consumer (DTC) television advertising for oncology products... Read More